N (%) of patients | N (IR) of deaths | HR (95% CI)a | |
---|---|---|---|
By sites of first malignancy | |||
Colon and Rectum | 6463 (17.8) | 681 (2.1) | 0.95 (0.88–1.03) |
Uterine corpus | 6057 (16.7) | 610 (1.8) | 0.98 (0.90–1.06) |
Blood | 3887 (10.7) | 407 (2.3) | 1.16 (1.05–1.28) |
Skin | 3489 (9.6) | 309 (1.6) | 0.96 (0.86–1.07) |
Lung and Bronchus | 3092 (8.5) | 418 (4.1) | 1.85 (1.68–2.03) |
Thyroid | 2722 (7.5) | 207 (1.4) | 0.93 (0.81–1.07) |
Ovary | 1612 (4.4) | 181 (2.3) | 1.19 (1.02–1.37) |
Urinary Bladder | 1547 (4.3) | 177 (2.2) | 1.22 (1.05–1.42) |
Kidney | 1382 (3.8) | 116 (1.9) | 1.01 (0.84–1.21) |
Uterine cervix | 1123 (3.1) | 132 (2.0) | 1.01 (0.85–1.20) |
Others | 4939 (13.6) | 591 (2.9) | 1.35 (1.25–1.47) |
By tumor stage of first malignancy b | |||
Localized | 20,100 (62.3) | 1906 (1.8) | 0.98 (0.94–1.03) |
Regional | 7088 (22.0) | 802 (2.4) | 1.20 (1.12–1.29) |
Distant | 2661 (8.3) | 379 (4.7) | 1.63 (1.47–1.80) |
Unstaged | 2394 (7.4) | 335 (3.3) | 1.36 (1.22–1.51) |
By chemotherapy and radiotherapy for first malignancy | |||
No/unknown | 24,129 (66.4) | 2580 (2.1) | 1.09 (1.05–1.13) |
Radiotherapy only | 4816 (13.3) | 470 (2.3) | 1.12 (1.03–1.23) |
Chemotherapy only | 4796 (13.2) | 505 (2.0) | 1.12 (1.02–1.22) |
Chemotherapy plus radiotherapy | 2572 (7.1) | 274 (2.9) | 1.44 (1.28–1.63) |